Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT03546907 · COMPLETED
Trial details
- NCT number
- NCT03546907
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-16
- Primary completion
- 2019-10-03
- Enrollment
- 343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.